Haven't used ReThink Pharmaceuticals yet?
Ask Trustburn

Ask Trustburn about ReThink Pharmaceuticals

Based on 9 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Barbara Eichinger
Reviews 1

ReThink Pharmaceuticals has been providing outstanding products and services. The quality of their medications is excellent, and their customer service is top-notch. I highly recommend them for all your pharmaceutical needs.

Art Phillips
Reviews 1

I have been ordering medications from ReThink Pharmaceuticals for quite some time now, and I am very pleased with their products and services. The quality of their medications is excellent, and their customer service is top-notch.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="rethinkpharmaceuticals-com" data-lang="en"></div>
More widgets

About ReThink Pharmaceuticals

ReThink offers a distinct algorithm based on evolutionary genomics (Phylogenetic Profiling) and innovative bioinformatics for drug repurposing.

They discover new indications for drugs in the market and under clinical development, as well as shelved drugs which failed for efficacy reasons in clinical trials.

Their breakthrough approach goes beyond the boundaries of published data (whereas other companies are based on the same data-sets) dramatically expanding the spectrum of connections between drugs and diseases that allows them to generate novel and highly accurate findings.

They look to work in partnership and collaboration with the pharma industry, medical institutions and rare disease foundations to create value by enhancing the potential clinical and commercial success of repurposing options for existing assets.